It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
INTRODUCTION: Measurement of peak nasal inspiratory flow (PNIF) has gained wide acceptance among clinicians due to its
simplicity. Unfortunately, due to the lack of reference values, a single measurement does not provide any relevant information
on the degree of nasal obstruction. We have therefore attempted to evaluate parameters that would be useful for
establishing reference ranges for PNIF.
MATERIAL AND METHODS: The study was a part of an epidemiological study ECAP (Epidemiologia Chorób Alergicznych w
Polsce [The Epidemiology of Allergic Diseases in Poland]). Inhabitants of Wrocław, Poland, aged 6–7, 13–14 and 20–45
years were randomly selected for the study. All the subjects had their medical history taken and their PNIF measured (using
an In-Check inspiratory flow meter manufactured by Clement-Clark). Patients with a diagnosis of rhinitis and/or asthma were
excluded from the study. In each subject, the highest of the five measurements (PNIF MAX) was included in the analysis.
RESULTS: A total of 221 healthy individuals were enrolled in the study. PNIF MAX differed significantly between females and
males. A significant correlation was observed between height and PNIF MAX, although no such correlation was found
between age and PNIF MAX. For this reason, in order to establish a reference range for PNIF, a regression equation that
included sex and height was analysed. The following relationship was arrived at: PNIF MAX = –137.7 – 22.5x + 1.7y,
where x is the sex (1 for females and 0 for males) and y is the height. The coefficient of determination (R²) for this relationship
was 0.45, which means that the regression equation explains about 45% of the observed variability of PNIF MAX.
CONCLUSIONS: We found that PNIF MAX correlated with sex and height and that it did not correlate with age. The difficulties
in establishing normal ranges for PNIF are most likely due to the differences in nasal anatomy between the subjects.
Pneumonol. Alergol. Pol. 2011; 79, 5: 320–325
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer